GLP1R and Other metabolic disease: Before PSM, GLP-1 RA Users were older, more frequently female, and exhibited a substantially higher prevalence of endocrine, nutritional and metabolic disorders, as well as gastrointestinal system disorders, compared to Non–GLP-1 RA Users (Table 1).